Third Harmonic Bio Gross Profit

Third Harmonic Bio posts a gross profit of $-12K as of March 2025. That compares with $470K in the prior-year period — down 102.6% year over year. That is below the sector sector average of $790M. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Third Harmonic Bio's gross profit was $470K. The latest reading is $-12K — a 102.6% year-over-year decrease (period ending March 2025). Use the history and growth charts on this page for a longer lookback.

For its sector stocks, a gross profit near $790M is typical. Third Harmonic Bio's $-12K is lower that level. That is roughly 100.0% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Gross Profit is one piece of Third Harmonic Bio's financial statement story. At $-12K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for THRD's gross profit usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $790M), and (3) consistency with growth and profitability. This page covers the first two; Third Harmonic Bio's other metric pages and overview cover the third.